دورية أكاديمية

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data

التفاصيل البيبلوغرافية
العنوان: Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data
المؤلفون: Coles, AJ, Jones, JL, Vermersch, P, Traboulsee, A, Bass, AD, Boster, A, Chan, A, Comi, G, Fernandez, O, Giovannoni, G, Havrdova, EK, LaGanke, C, Montalban, X, Oreja-Guevara, C, Piehl, F, Wiendl, H, Ziemssen, T
المصدر: Multiple sclerosis (Houndmills, Basingstoke, England). 28(5):842-846
مصطلحات موضوعية: Medicin och hälsovetenskap
URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:148334361
قاعدة البيانات: SwePub
الوصف
تدمد:14770970
DOI:10.1177/13524585211061335